CYFRA 21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2669-2672

  Ebert, W ^a   Muley, Th ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CYFRA 21 1; Disease monitoring; Non small cell lung cancer

Indexed keywords

CYTOKERATIN 19 FRAGMENT;

ADULT; AGED; BLOOD LEVEL; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME IMMUNOASSAY; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; KERATINS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032780609     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, Lee JS, Dhingra H, de Caro L, Chasen M, Mc Gavran M, Atkinson EN and Hong WK: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86: 637-680, 1994.
2. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WI, Perry MC, Carey RW, Frei EF and Green MR: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323: 940-945, 1990.
3. Fernandez C, Rossell R and Abab-Esteve A: Quality of life during chemotherapy in non-small cell lung cancer patients. Acta Oncol 28: 29-33, 1989.
4. Ebert W, Dienemann H, Fateh-Moghadam A, Scheulen M, Konietzko N, Schleich T and Bombardieri E: Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron specific enolase in lung cancer. Results of an international multicentre study. Eur J Clin Chem Clin Biochem 32: 189-199, 1994.
5. World Health Organization: Histological classification of lung tumors. WHO, Geneva, 1981.
6. Hermanek P and Sobin L: TNM classification of malignant tumors. International Union against Cancer (UICC), 4th ed, Berlin, Springer, 1987.
7. WHO. Handbook of reporting results of cancer treatment. Geneva, World Health Organization offset publication No. 48, 1979.
8. Costongs GMPJ, Janson PCW, Bas BM, Hermans J, Brombacher PJ and van Wersch JWJ: Short-term and long-term intra-individual variation and critical difference of haematological laboratory parameters. J Clin Chem Clin Biochem 23: 69-76, 1985.
9. Van der Gaast A, Kok TC, Kho GS, Blijenberg BG and Splinter TAW: Disease monitoring by the tumour markers Cyfra 21-1 and TPA in patients with non-small cell lung cancer. Eur J Cancer 31A: 1790-1793, 1995.
10. Bac DJ, Splinter TAW, Kok TC and van der Gaast A: Evaluation of CA 19-9 serum levels for monitoring disease activity during chemotherapy of pancreatic adenocarcinoma. J Cancer Res Clin Oncol 117: 263-265, 1991.